nav_top

Username:
Password:

Remember Me
Forgot Password

Benefits of Membership
Search By Keyword Or Search By

Improving Chronic Care Management: Connecting Health Information Technology and Quality Measurements

Please review the following information and click "continue" at the bottom of this screen to enter the activity.

Release Date: March 1, 2008
Expiration Date:
March 1, 2009

Target Audience:
Pharmacists and Physicians

Purpose Statement:
Managing chronic disease is a major problem for the health care system in the United States. Almost one-half of the population has at least 1 chronic disease and 50% have multiple chronic conditions. Currently, managed care organizations, health care providers, and health IT companies, are playing a major role in shaping care management. Collaborative care models for the treatment of diabetes have already demonstrated positive results with pilot programs and adherence initiatives. Common goals among managed care organizations and healthcare providers that measure improved health outcomes on a Health Information Technology (HIT) platform will improve collaborative chronic care. This activity evaluates the characteristics of chronic care management programs and their use of HIT.

Learning Objectives:
After completing this activity, the participant should be better able to:

  1. Identify the impact of HIT on collaborative chronic care management.
  2. Describe current HIT strategies being used by MCOs in chronic care disease management.
  3. Review medication therapy management programs in the treatment of diabetes and their impact on outcomes.
  4. Cite the results of current IT initiatives for diabetes adherence and disease management programs.
  5. Describe how to implement HIT and collaborative chronic care initiatives among key stakeholders.

Accreditation Statement:
Physicians
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Impact Education, LLC. PIM is accredited by the ACCME to provide continuing medical education for physicians.

Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacists
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Program Number: 809-999-07-077-H04

Faculty:
Janet M. Marchibroda, MBA

Chief Executive Officer
eHealth Initiative
Washington, DC

Robert McMahan, PharmD, MBA, MATS
Director of Pharmacy
Fidelis Care
New York, NY

Kathleen Wyne, MD, PhD, FACE
Assistant Professor
Division of Endocrinology and Metabolism
University of Texas Southwestern Medical School
Dallas, TX

Method of Participation:
To receive a statement of credit, you must:

  • Review the full content of the journal supplement
  • Successfully complete the post-test within 2 attempts (70% or better)
  • Complete the activity evaluation

Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation form.

Fee:
There is no fee for this educational activity.

Commercial Support:
This activity is supported by an educational grant from GlaxoSmithKline.

Disclosure of Conflicts of Interest:
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Rob McMahan, PharmD, MBA, MATS No financial interest/relationships with financial interests relating to the topic of this activity
Kathleen Wyne, MD, PhD, FACE Fees for Non-CME Services: Boehringer Ingelheim, GlaxoSmithKline, Novo Nordisk, Merck & Co., Inc., Novartis Pharmaceuticals, Eli Lilly & Company
Contacted Research: Sanofi-Aventis, Novo Nordisk
Janet Marchibroda, MBA Fees for Non-CME Services: Pfizer

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.

Name of Planner or Manager Reported Financial Relationship
Lauren Cole (Impact Education, LLC) No financial interest/relationships with financial interests relating to the topic of this activity
Trace Hutchison, PharmD (PIM) No financial interest/relationships with financial interests relating to the topic of this activity

Disclosure of Off-Label Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. If an off-label (unapproved) use is mentioned, each author is responsible for identifying the drug and its off-label indication. Postgraduate Institute of Medicine (PIM), Impact Education, LLC, and GlaxoSmithKline do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, Impact Education, LLC, and GlaxoSmithKline. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

This activity is jointly sponsored by Postgraduate Institute for Medicine and Impact Education, LLC.

Software Requirements

PC
Windows 2000 or higher
Internet Explorer 5.5 or higher or Firefox
*Adobe Acrobat Reader Click here to download

*Required for Printable PDF
MAC
Mac OS 10.2.8
Safari
*Adobe Acrobat Reader Click here to download

*Required for Printable PDF


Select a Profession to Continue: